News

< Back

Upcoming Industry Event: AFAR Board Members to Present at NY Academy of Sciences Symposium

On May 9th, 2014 AFAR board members Kevin Lee, PhD, and Nir Barzilai, MD, will present at the New York Academy of Sciences’ simultaneous one-day conference and webinar entitled “The Biology of Aging: Novel Drugs Targets for Neurodegenerative Diseases.” The event has two primary focuses: basic biology of aging-related pathways and drug development programs for neurodegenerative disease such a as Alzheimer’s disease.

Event: The New York Academy of Sciences conference and webinar on “The Biology of Aging: Novel Drug Targets for Neurodegenerative Disease”

Date: May 9, 2014

Time: 8:00am – 4:00pm

Location: Online or The New York Academy of Science

The New York Academy of Science
7 World Trade Center
250 Greenwich Street, 40th floor
New York, NY 10007-2157

For more information or to register for either the in person or online event please visit The New York Academy of Sciences’ website here: http://www.nyas.org/Events/Detail.aspx?cid=8f235d9a-d907-45e9-8c1d-8f26cfc817d5

Interested in the biology of aging? Visit AFAR’s comprehensive Biology of Aging page on our educational webpage, InfoAging.org.

More Recent News

View All News >
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD , on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President